The remarkable delay in onset of certain cancers afforded by global reduction of endogenous Myc suggests the existence of a bottleneck, sometime in early tumour evolution, whose transit is dependent on exceeding a critical threshold level of Myc expression, above that needed for most quotidian physiological Myc functions. The gene discussed is MYC; the disease is neoplasm.